Introduction: Combination therapy with both basal insulin (BI) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is an effective treatment in patients with uncontrolled type 2 diabetes mellitus (T2DM). The recent development and release of a fixed-ratio combination of slow-release insulin degludec and the GLP-1RA liraglutide (IDegLira) represents an improvement to this therapy. We have conducted a real-world evidence study in Italian patients with T2DM to evaluate whether the encouraging clinical trial results obtained with IDegLira, which became available in Italy in January 2018, can be confirmed in Italian clinical practice.
Methods: This was a multicenter, retrospective, observational study in patients with T2DM treated with IDegLira from January to December 2018. Prior to the initiation of IDegLira therapy, patients were treated with BI with or without one or more concomitant oral antidiabetic drugs (BOT group) or according to the basal bolus protocol (BI and rapid-acting insulin treatment; BB group).
Results: A total of 244 patients were included in the present study, of whom 186 were in the BOT group and 58 in the BB group. Following the switch to IDegLira therapy, glycemic control improved in both groups, with significant reductions in glycated hemoglobin after 6 and 12 months of treatment in the BOT group and after 6 months of treatment in the BB group. No gain in body weight and body mass index and reductions in fasting plasma glucose and number of concomitant diabetic medications (in BOT patients) were observed. All results obtained during the study were achieved at a moderate dose of IDegLira.
Conclusion: The findings from this study show that in a real-world setting, the switch to IDegLira treatment is a valid option for patients who are failing to achieve glycemic control targets and/or struggling with the side effects, such as weight gain and hypoglycemia, of other insulin therapies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843811 | PMC |
http://dx.doi.org/10.1007/s13300-020-00945-4 | DOI Listing |
J Exp Bot
December 2024
Área de Fisiología Vegetal, Departamento de Ingeniería y Ciencias Agrarias, Universidad de León, León, Spain.
While evolutionary studies indicate that the most ancient groups of organisms on Earth likely descended from a common wall-less ancestor, contemporary organisms lacking a carbohydrate-rich cell surface are exceedingly rare. By developing a cell wall to cover the plasma membrane, cells were able to withstand higher osmotic pressures, colonise new habitats and develop complex multicellular structures. This way, the cells of plants, algae and microorganisms are covered by a cell wall, which can generally be defined as a highly complex structure whose main framework is usually composed of carbohydrates.
View Article and Find Full Text PDFJ Exp Bot
December 2024
Group of Antioxidants, Free Radicals and Nitric Oxide in Biotechnology, Food and Agriculture, Department of Biochemistry, Cell and Molecular Biology of Plants, Estación Experimental del Zaidín, Spanish National Research Council (CSIC), Granada, Spain.
Cellular signaling is a key component of both intra- and intercellular communication, playing a crucial role in the development of higher plants as well as in their responses to environmental conditions of both abiotic and biotic origin. In recent decades, molecules such as hydrogen peroxide (H2O2), nitric oxide (NO), hydrogen sulfide (H2S), and melatonin have gained significant relevance in plant physiology and biochemistry due to their signaling functions and their interactions, forming a comprehensive cellular communication network. The Solanaceae family of plants includes a group of horticultural crops of great global importance, for instance, tomatoes, eggplants, and peppers, which are of major agroeconomic significance due to their widespread cultivation and consumption.
View Article and Find Full Text PDFBot Stud
December 2024
Department of System Analysis and Information Technologies, Kazan Privolzhsky Federal University, Kazan, Russian Federation.
Background: The research aims to assess the effectiveness of artificial intelligence models in predicting the risk level in tulip greenhouses using different varieties. The study was conducted in 2022 in the Almaty region, Panfilov village.
Results: Two groups of 10 greenhouses each (area 200 m2) were compared: the control group used standard monitoring methods, while the experimental group employed AI-based monitoring.
Clin Gastroenterol Hepatol
December 2024
Health Services Research, Durham University, Durham, United Kingdom.
Background And Aims: Budesonide orodispersible tablets (BOT) have been shown to be safe and effective in phase 3 double-blind trials of induction and 48-week maintenance therapy of eosinophilic esophagitis (EoE). We now analyzed the long-term efficacy and safety of BOT in a 96-week open-label extension (OLE) study.
Methods: All EoE patients in the 48-week double-blind maintenance study were eligible to receive BOT treatment for up to 96 weeks.
Ann Bot
December 2024
Laboratório de Anatomia Vegetal (LAVeg), Federal University of Rio Grande do Sul, Av. Bento Gonçalves, 9500, Porto Alegre, RS, Brazil.
Background And Aims: Recent studies have documented numerous morphoanatomical variations for the seed coat in Bromeliaceae. However, the structural diversity and character evolution of the embryo within this family remain largely unexplored. Given the embryo's significance in plant diversification, this research aims to investigate the morphology and key anatomical features of Bromeliaceae embryos, providing insights into character evolution, taxonomic applications, and reproductive biology.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!